Biotech comes to its 'antisenses' after hard-won drug approval

Jiang Kevin

首页> 外文期刊>Nature medicine >Biotech comes to its 'antisenses' after hard-won drug approval

【24h】

Biotech comes to its 'antisenses' after hard-won drug approval

机译：在获得来之不易的药物批准后，生物技术公司开始了其“反义”活动

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Nature medicine》 |2013年第3期|共1页
作者
Jiang Kevin;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Biotech comes to its 'antisenses' after hard-won drug approval [J] . Jiang Kevin Nature medicine . 2013,第3期

机译：在获得来之不易的药物批准后，生物技术公司开始了其“反义”活动
2. The economic consequences of US FDA new drug approvals: evidence from Taiwan pharmaceutical and biotech companies [J] . Yong-Jie Chen, Zhi-Yuan Feng, Yueh-Ping Li, Innovation: Organization & Management . 2021,第3期

机译：美国FDA新药物批准的经济后果：来自台湾制药和生物技术公司的证据
3. FDA Acts to Speed Up Biotech Drug Approvals [J] . Chemical Market Reporter Group Chemical Market Reporter . 2002,第9期

机译：FDA采取行动加快生物技术药物的批准
4. The current status and value creation of unlisted Biotech Drug Discovery/Development Firms (Biotech DDFs) in Japan: A holistic approach [C] . Sakurai, Mitsuya, Munisi, Hawa Issa, Kakihara, Hiroaki, Portland International Conference on Management of Engineering & Technology . 2014

机译：日本未上市生物技术药物发现/开发公司（Biotech DDFs）的现状和价值创造：整体方法
5. Meta-Analysis to Identify and Evaluate Factors Associated with Regulatory Approval of Orphan Drugs (OD) to Develop an Algorithm for Predicting Regulatory Approval (Success) and to Develop a Standardized Tool to Improve Orphan Drug Portfolio Decision-Making [D] . Florent, Milky C. 2019

机译：荟萃分析，以识别和评估与孤儿药物监管批准（OD）相关的因素，以开发预测监管批准（成功）的算法，并开发标准化工具以改善孤儿药物投资组合决策
6. Trends in global approvals of biotech crops (1992–2014) [O] . Rhodora R Aldemita, Ian Mari E Reaño, Renando O Solis, 2015

机译：全球转基因作物批准的趋势（1992年至2014年）
7. Characteristics of pre-approval and post-approval studies for drugs granted accelerated approval by the US food and drug administration [O] . Naci, Huseyin, Smalley, Katelyn R., Kesselheim, Aaron S. 2017

机译：美国食品和药物管理局加速批准的药品批准前和批准后研究的特征

Biotech comes to its 'antisenses' after hard-won drug approval

著录项

相似文献

相关主题

期刊订阅